{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:05:09Z","timestamp":1764173109700},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":571,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The efficacy of omeprazole\u2010based eradication therapies has been determined mostly in populations with low to moderate prevalence of metronidazole resistant <jats:italic>Helicobacter pylori,<\/jats:italic> yet resistance is high in many regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim and Methods:<\/jats:title><jats:p>The <jats:italic>H. pylori<\/jats:italic> eradication and duodenal ulcer healing rates after 1\u2003week of either omeprazole 40\u2003mg mane, amoxycillin 500\u2003mg t.d.s. and metronidazole 400\u2003mg t.d.s. (OAM) or omeprazole 20\u2003mg b.d., metronidazole 400\u2003mg b.d. and clarithromycin 250\u2003mg b.d. (OMC) were compared in a randomized trial in Australia and New Zealand. Patients had a further 1\u2003week of omeprazole 20\u2003mg. Outcome was assessed at 6\u2003weeks with stringent criteria (endoscopy, biopsies and <jats:sup>13<\/jats:sup>C\u2010urea breath test).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Of 220 subjects randomized, the <jats:italic>H. pylori<\/jats:italic> eradication rates (all patients treated\/per protocol) were 82%\/85% for OMC and 58%\/63% for OAM (<jats:italic>P<\/jats:italic>= 0.001). Pre\u2010treatment metronidazole resistance was present in 56% and clarithromycin resistance in 6%. The eradication rate for primary metronidazole resistance isolates treated with OMC was 80% (CI: 65\u201390%) compared with 45% (CI: 29\u201362%) for OAM, whereas for sensitive organisms, the eradication rates were 94% (CI: 79\u201399%) and 79% (CI: 62\u201391%), respectively. Duodenal ulcer healing was 96% for OMC and 87% for OAM. Compliance was excellent and both treatments were well\u2010tolerated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>OMC is a well\u2010tolerated, effective therapy for <jats:italic>H. pylori<\/jats:italic> eradication and duodenal ulcer healing in this region despite the high metronidazole resistance rate. OAM is less effective, largely due to the impact of metronidazole resistance.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00776.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:49Z","timestamp":1047354109000},"page":"751-758","source":"Crossref","is-referenced-by-count":37,"title":["Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for <i>Helicobacter pylori<\/i> eradication, in a region of high primary metronidazole resistance: the HERO study"],"prefix":"10.1111","volume":"14","author":[{"family":"Katelaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Adamthwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Midolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Yeomans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70119-8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1998.tb00660.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00568.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.5.675"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.11.1562"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01960875"},{"key":"e_1_2_6_8_2","first-page":"743","article-title":"Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens","volume":"86","author":"Bell GD","year":"1993","journal-title":"Q J Med"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00349.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80264-3"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80277-1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00535.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1998.tb04452.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00856.x"},{"key":"e_1_2_6_17_2","first-page":"A187","article-title":"Proton pump inhibitor triple therapies for Helicobacter pylori in clinical practice: the impact of clarithromycin and the \u2018cost\u2019 of metronidazole resistance","volume":"13","author":"Katelaris PH","year":"1998","journal-title":"J Gastroenterol Hepatology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.6.735"},{"key":"e_1_2_6_19_2","first-page":"1865","article-title":"Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13C\u2010urea breath test","volume":"88","author":"Klein PD","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709007677"},{"key":"e_1_2_6_21_2","first-page":"A144","article-title":"Cut\u2010off point for 13C\u2010urea breath test","volume":"110","author":"Johnston BJ","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_23_2","unstructured":"Australian Gastroenterology Institute.Helicobacter pylori: Guidelines for Healthcare Workers 3rd edn. Sydney Australia: Gastroenterological Society of Australia 1999."},{"key":"e_1_2_6_24_2","first-page":"A205","article-title":"Efficacy of repeat treatments after initial failure of Helicobacter pylori eradication therapy","volume":"116","author":"Katelaris PH","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00504.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00776.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00776.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00776.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:45:59Z","timestamp":1698587159000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00776.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00776.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00776.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}